Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LivaNova (LIVN) Change in Receivables (2016 - 2025)

Historic Change in Receivables for LivaNova (LIVN) over the last 11 years, with Q3 2025 value amounting to -$7.8 million.

  • LivaNova's Change in Receivables rose 1312.73% to -$7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year increase of 28109.38%. This contributed to the annual value of -$11.1 million for FY2024, which is 13831.76% down from last year.
  • According to the latest figures from Q3 2025, LivaNova's Change in Receivables is -$7.8 million, which was up 1312.73% from $9.8 million recorded in Q2 2025.
  • LivaNova's Change in Receivables' 5-year high stood at $20.6 million during Q4 2023, with a 5-year trough of -$9.0 million in Q3 2024.
  • Its 5-year average for Change in Receivables is $2.3 million, with a median of $3.1 million in 2022.
  • Within the past 5 years, the most significant YoY rise in LivaNova's Change in Receivables was 85341.77% (2023), while the steepest drop was 40589.02% (2023).
  • Over the past 5 years, LivaNova's Change in Receivables (Quarter) stood at $7.9 million in 2021, then tumbled by 60.16% to $3.1 million in 2022, then surged by 555.8% to $20.6 million in 2023, then crashed by 69.14% to $6.4 million in 2024, then tumbled by 223.21% to -$7.8 million in 2025.
  • Its Change in Receivables was -$7.8 million in Q3 2025, compared to $9.8 million in Q2 2025 and $3.9 million in Q1 2025.